EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Rachel Strykowski, Ayodeji Adegunsoye

Immunology and Allergy Clinics of North America · 2023-05 · 43 (2) · 209-228

DOI: 10.1016/j.iac.2023.01.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2023-05. Verfasst von Rachel Strykowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary and Critical Care, Department at University of Chicago, 5841 South Maryland Avenue, MC 6076, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: NHLBI NIH HHS, Pulmonary Fibrosis Foundation, Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes. Management often encompasses pharmacotherapy, supportive interventions, addressing comorbidities when present, and treating hypoxia with ambulatory O2. Consideration for antifibrotic therapy and lung transplantation evaluation should occur early. Patients with ILD other than IPF, and who have radiological evidence of pulmonary fibrosis, may have progressive pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisLung Diseases, InterstitialHumansDisease ProgressionTomography, X-Ray ComputedFibrosis

Stichwörter der Autor:innen

Diffuse parenchymal lung diseaseIdiopathic pulmonary fibrosisInterstitial lung diseaseProgressive pulmonary fibrosis

Autor:innen und Institutionen

  • Section of Pulmonary and Critical Care, Department at University of Chicago, 5841 South Maryland Avenue, MC 6076, Chicago, IL 60637, USA.
  • Interstitial Lung Disease Program, Section of Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA. Electronic address: deji@uchicago.edu.

Förderung

  • NHLBI NIH HHS
  • Pulmonary Fibrosis Foundation
  • Roche
  • National Heart, Lung, and Blood Institute
  • Boehringer Ingelheim

Zitieren

APA

Strykowski, R., & Adegunsoye, A. (2023). Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. Immunology and Allergy Clinics of North America, 43(2), 209-228. https://doi.org/10.1016/j.iac.2023.01.010

Vancouver

Strykowski R, Adegunsoye A. Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. Immunology and Allergy Clinics of North America. 2023;43(2):209-228. doi:10.1016/j.iac.2023.01.010

BibTeX
@article{Strykowski2023,
  author = {Strykowski, Rachel and Adegunsoye, Ayodeji},
  title = {Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2023},
  volume = {43},
  number = {2},
  pages = {209--228},
  doi = {10.1016/j.iac.2023.01.010}
}
Kostenlos starten →